Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailCarcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter la radiothérapie pour certaines patientes opérées ?
Coucke, Philippe ULiege; Barthelemy, Nicole ULiege; Jansen, Nicolas ULiege et al

in Revue Médicale de Liège (2008), 63(2), 75-81

Dans le cadre de la prise en charge multidisciplinaire du carcinome intracanalaire du sein (carcinome intra-canalaire in situ = DCIS = Ductal Carcinoma In Situ), on évoque souvent la possibilité de ... [more ▼]

Dans le cadre de la prise en charge multidisciplinaire du carcinome intracanalaire du sein (carcinome intra-canalaire in situ = DCIS = Ductal Carcinoma In Situ), on évoque souvent la possibilité de renoncer à la radiothérapie complémentaire après un geste de chirurgie conservatrice. S’il est vrai que la radiothérapie, dans ce contexte, n’apporte pas de bénéfice en survie, il n’en reste pas moins qu’on observe à long terme un effet bénéfique en contrôle local. Il existe un effet significativement marqué sur le taux de rechute de type DCIS et de type invasif dans les différentes études randomisées destinées à éclaircir la problématique du rôle de la radiothérapie. La question est de savoir si on peut distinguer un sous-groupe de patientes pour qui le contrôle local n’est pas modifié par l’adjonction d’une radiothérapie adjuvante. Pour l’instant, nous ne sommes pas à même de définir ce sous-groupe, car les critères de sélection n’ont pas été mis à l’épreuve dans le cadre d’un essai randomisé. Faute de ces données, il nous semble plus adéquat de proposer jusqu’à preuve du contraire, une radiothérapie aux patientes opérées, même si l’intervention est a priori radicale, mais conservatrice, et même si les facteurs pronostiques semblent plutôt favorables. Cependant, la radiothérapie n’est pas indiquée après une mastectomie. [less ▲]

Detailed reference viewed: 76 (7 ULiège)
Full Text
Peer Reviewed
See detailCarcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter les radiothérapie pour certaines patientes opérées?
Coucke, Philippe ULiege; Barthelemy, Nicole ULiege; Jansen, Nicolas ULiege et al

in Revue Médicale de Liège (2008), 63 (2)

Dans le cadre de la prise en charge multidisciplinaire du carcinome intracanalaire du sein (carcinome intra-canalaire in situ = DCIS = Ductal Carcinoma In Situ), on évoque souvent la possibilité de ... [more ▼]

Dans le cadre de la prise en charge multidisciplinaire du carcinome intracanalaire du sein (carcinome intra-canalaire in situ = DCIS = Ductal Carcinoma In Situ), on évoque souvent la possibilité de renoncer à la radiothérapie complémentaire après un geste de chirurgie conservatrice. S’il est vrai que la radiothérapie, dans ce contexte, n’apporte pas de bénéfice en survie, il n’en reste pas moins qu’on observe à long terme un effet bénéfique en contrôle local. Il existe un effet significativement marqué sur le taux de rechute de type DCIS et de type invasif dans les différentes études randomisées destinées à éclaircir la problématique du rôle de la radiothérapie. La question est de savoir si on peut distinguer un sous-groupe de patientes pour qui le contrôle local n’est pas modifié par l’adjonction d’une radiothérapie adjuvante. Pour l’instant, nous ne sommes pas à même de définir ce sous-groupe, car les critères de sélection n’ont pas été mis à l’épreuve dans le cadre d’un essai randomisé. Faute de ces données, il nous semble plus adéquat de proposer jusqu’à preuve du contraire, une radiothérapie aux patientes opérées, même si l’intervention est a priori radicale, mais conservatrice, et même si les facteurs pronostiques semblent plutôt favorables. Cependant, la radiothérapie n’est pas indiquée après une mastectomie. [less ▲]

Detailed reference viewed: 680 (23 ULiège)
See detailCarcinome parathyroïdien : Contrôle de l'hypercalcémie par immunothérapie
Betea, Daniela ULiege; Bradwel, A.; Valdes Socin, Hernan Gonzalo ULiege et al

in Annales d'Endocrinologie : XIXe Congrès de la Société Française d'Endocrinologie - Abstract book (2001)

Detailed reference viewed: 15 (0 ULiège)
See detailCarcinome parathyroïdien et immunothérapie
Beckers, Albert ULiege

Scientific conference (2005, October)

Detailed reference viewed: 5 (0 ULiège)
See detailCarcinome parathyroïdien et immunothérapie
Beckers, Albert ULiege

Scientific conference (2005, April 22)

Detailed reference viewed: 8 (0 ULiège)
See detailCarcinome parathyroïdien et immunothérapie
Beckers, Albert ULiege

Scientific conference (2004, November)

Detailed reference viewed: 8 (0 ULiège)
Full Text
Peer Reviewed
See detailLe carcinome parathyroïdien familial : une forme agressive d'hyperparathyroïdie primaire
Tudorescu, A; VROONEN, Laurent ULiege; BETEA, Daniela ULiege et al

in Annales d'Endocrinologie (2013, October), 74

Detailed reference viewed: 51 (3 ULiège)
Full Text
Peer Reviewed
See detailCardiac autonomic dysfunction in diabetic children.
Massin, M. M.; Derkenne, B.; Tallsund, M. et al

in Diabetes care (1999), 22(11), 1845-50

OBJECTIVE: Adults with type 1 diabetes may have abnormal alterations in heart rate variability (HRV) due to cardiac autonomic neuropathy. This prospective study was performed to determine whether HRV can ... [more ▼]

OBJECTIVE: Adults with type 1 diabetes may have abnormal alterations in heart rate variability (HRV) due to cardiac autonomic neuropathy. This prospective study was performed to determine whether HRV can be used to detect subclinical autonomic neuropathy in diabetic children. RESEARCH DESIGN AND METHODS: We examined five time domain and three frequency domain HRV indices determined from 24-h Holter recordings in 73 diabetic children and adolescents aged 3-18 years (mean 12.1 years) with a mean duration of diabetes of 55 months. The measures were compared with normal ranges. Z scores were established for each parameter and were compared with classic risk factors of other diabetic complications. RESULTS: Most HRV indices were significantly depressed in children aged > or = 11 years, and the levels of HRV abnormalities were significantly correlated with long-term metabolic control (mean GHb for 4 years) in that age-group. In younger patients, HRV indices were within the normal range and were not correlated with the level of metabolic control. Illness duration and microalbuminuria but not short-term metabolic control (most recent GHb) were also independently predictive of HRV abnormalities. CONCLUSIONS: These results suggest that early puberty is a critical period for the development of diabetic cardiac autonomic dysfunction. Therefore, all type 1 diabetic patients should be screened for this complication by HRV analysis beginning at the first stage of puberty regardless of illness duration, microalbuminuria, and level of metabolic control. [less ▲]

Detailed reference viewed: 11 (0 ULiège)
Full Text
See detailCardiac biomarkers : present and the future
LE GOFF, Caroline ULiege

Conference (2012)

Detailed reference viewed: 13 (1 ULiège)
Full Text
Peer Reviewed
See detailCardiac Biomarkers and Cycling Race
LE GOFF, Caroline ULiege; Kaux, Jean-François ULiege; Goffaux, Sébastien et al

in Journal of Sports Science & Medicine (2015), 14(2 (eCollection 2015 Jun)), 475-476

Detailed reference viewed: 12 (3 ULiège)
Full Text
Peer Reviewed
See detailCardiac computed tomography core syllabus of the European Association of Cardiovascular Imaging (EACVI).
Nieman, Koen; Achenbach, Stephan; Pugliese, Francesca et al

in European heart journal cardiovascular Imaging (2015)

The European Association of Cardiovascular Imaging (EACVI) Core Syllabus for Cardiac Computed Tomography (CT) is now available online. The syllabus lists key elements of knowledge in Cardiac CT. It ... [more ▼]

The European Association of Cardiovascular Imaging (EACVI) Core Syllabus for Cardiac Computed Tomography (CT) is now available online. The syllabus lists key elements of knowledge in Cardiac CT. It represents a framework for the development of training curricula and provides expected knowledge-based learning outcomes to the Cardiac CT trainees. [less ▲]

Detailed reference viewed: 22 (3 ULiège)
Full Text
Peer Reviewed
See detailCardiac concerns associated with strontium ranelate.
Reginster, Jean-Yves ULiege

in Expert opinion on drug safety (2014), 13(9), 1-5

Introduction: Strontium ranelate is proven to reduce vertebral and non-vertebral fracture risk in osteoporosis. Concerns about cardiac safety have led to a new contraindication to strontium ranelate in ... [more ▼]

Introduction: Strontium ranelate is proven to reduce vertebral and non-vertebral fracture risk in osteoporosis. Concerns about cardiac safety have led to a new contraindication to strontium ranelate in patients with uncontrolled hypertension and/or current or past history of ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease. Areas covered: A literature search was performed; data were also collected from the European Medicines Agency website. Randomised controlled trial (RCT) data indicate a higher incidence of non-adjudicated myocardial infarction (MI) with strontium ranelate versus placebo (1.7 vs 1.1%; odds ratio [OR]: 1.6; 95% CI: 1.07 - 2.38; p = 0.020) (Mantel-Haenzel estimate of the OR). There was no increase in cardiovascular mortality. MI risk was mitigated by excluding patients with cardiovascular contraindications (OR: 0.99; 95% CI: 0.48 - 2.04; p = 0.988). Three observational studies performed in the context of real-life medical practice in the UK and Denmark did not report a signal. Expert opinion: The increased risk for cardiac events with strontium ranelate has been detected in RCTs but not in real life. Excluding patients with cardiovascular contraindications appears to be an effective measure for controlling the risk of MI. Strontium ranelate remains a useful therapeutic alternative in patients with severe osteoporosis without cardiovascular contraindications who are unable to take another osteoporosis treatment. [less ▲]

Detailed reference viewed: 12 (4 ULiège)
Full Text
Peer Reviewed
See detailCardiac CT angiography: technical aspects in 2012.
Ghekiere, O.; Nchimi Longang, Alain ULiege

in JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR) (2013), 96(6), 401-2

Detailed reference viewed: 24 (2 ULiège)
See detailCardiac dysfunction in and prognostic factors of the systemic inflammatory response syndrome in dogs
Gommeren, Kris ULiege

Master of advanced studies dissertation (2011)

Detailed reference viewed: 12 (1 ULiège)
Peer Reviewed
See detailCardiac gated pinhole SPECT in living rat: filtered backprojection versus iterative reconstruction.
Vanhove, Christian; Franken, Philippe R.; Lahoutte, Tony et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (2003, May), 44(5), 276-277

Detailed reference viewed: 21 (1 ULiège)
Full Text
Peer Reviewed
See detailCardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
MOONEN, Marie ULiege; Oury, Cécile ULiege; Lancellotti, Patrizio ULiege

in Current Oncology Reports (2017), 19(10), 63

Contemporary cancer management has increased the overall number of cancer survivors, but cardiotoxicity remains a subject of concern, which is a major cause of noncancer mortality among survivors. Among ... [more ▼]

Contemporary cancer management has increased the overall number of cancer survivors, but cardiotoxicity remains a subject of concern, which is a major cause of noncancer mortality among survivors. Among the potential cardiovascular complications, left ventricular (LV) systolic dysfunction is a poor prognostic factor. The importance of its early detection is based on the principle that the likelihood of response to heart failure (HF) treatment is temporally related to the initiation of HF treatment. For these reasons, cardiac monitoring is commonly applied in general practice, based on serial measurements of LV ejection fraction (LVEF); transthoracic echocardiography (TTE) is generally used. However, the LVEF, as a diagnostic and predictive parameter, has significant limitations, which calls for more effective multimodality imaging strategies. This approach requires further study, but there is increasing available data in the literature, encouraging the combination of multimodality imaging parameters and techniques for early cancer therapeutic-related cardiac dysfunction (CTRCD) detection. [less ▲]

Detailed reference viewed: 19 (0 ULiège)
See detailCardiac markers: an update
Chapelle, Jean-Paul ULiege

Conference (2000, January)

Detailed reference viewed: 4 (0 ULiège)
Full Text
Peer Reviewed
See detailCardiac metastasis from malignant melanoma.
Lempereur-Legros, Sophie ULiege; Radermecker, Marc ULiege; Soyeur, Daniel ULiege et al

in Revue Médicale de Liège (2009), 64

Detailed reference viewed: 84 (5 ULiège)